Big Pharma’s Covid Vaccine

This crisis affects humanity in its entirety: 7.8 billion people. 

Worldwide, people are led to believe that the corona vaccine is a solution. And that “normality” will then be restored.

The following text is chapter VIII of Michel Chossudovsky’s E-Book.

.

.

To access the full document (Ten Chapters)

click below

The 2020-21 Worldwide Corona Crisis: Destroying Civil Society, Engineered Economic Depression, Global Coup d’État and the “Great Reset”

***

Introduction

The Covid-19 vaccine is profit driven. The US government had already ordered 100 million doses back in July 2020 and the EU is to purchase 300 million doses. It’s Big Money for Big Pharma, generous payoffs to corrupt politicians, at the expense of tax payers.

The objective is ultimately to make money, by vaccinating the entire planet of 7.8 billion people for SARS-CoV-2.

The Covid vaccine in some cases envisages more than one shot. If this initiative goes ahead as planned, it would be the largest vaccine project in World history and the biggest money making operation for Big Pharma.

The Second Wave of the pandemic commenced in October 2020. The Pfizer Moderna corona vaccine was launched in early November 2020.

Worldwide, people are led to believe that the corona vaccine is a solution. And that “normality” will then be restored.

How is it that a vaccine for the SARS-CoV-2 virus, which under normal conditions would take years to develop, was promptly launched on the 9th of November 2020?

Moreover, the vaccine announced by Pfizer, Moderna Inc, AstraZeneka and Johnson and Johnson (J & J) is based on an experimental gene editing mRNA technology which has a bearing on the human genome. Coupled with the mRNA vaccine initiative is the development of a so-called digital passport which will be imposed on entire populations. (See analysis below).

And why do we need a vaccine for Covid-19 when the WHO, the US Center for Disease Control and Prevention (CDC) as well as numerous scientists have confirmed unequivocally that Covid-19 is  “similar to seasonal influenza”.

The mRNA Vaccine is “Unapproved” and “Experimental” 

Four major companies including Pfizer Inc, Moderna Inc, AstraZeneca and Johnson and Johnson (J & J) are currently involved (early 2021) in marketing the experimental mRNA vaccine with the relentless support of national governments.

Amply documented, barely reported by the media, numerous cases of  deaths and injury have occurred.

The “Green Light” to market the experimental mRNA vaccine was granted back in December 2020, despite the fact that according to the FDA, the vaccine is an “unapproved product”.

The FDA in an ambiguous statement has provided a so-called Emergency Use Authorization (EUA) to the Pfizer-BioNTech vaccine, namely “to permit the emergency use of the unapproved product, … for active immunization…” (see below)

There is something fishy and “contradictory” in this statement. The experimental Pfizer mRNA vaccine is both “unapproved” and “permitted”.

I have checked this statement with a prominent lawyer. It is blatantly illegal to market an “unapproved product”.

In the US, the Pfizer-Moderna vaccine is categorized by the CDC as an “investigational drug”. “The emergency use” clause is there to justify the launching of what might be described as an “illegal drug”.

There is an ongoing fear campaign but there is no “Emergency” which justifies “Emergency Use”. Why?

  1. Both the WHO and the CDC have confirmed that Covid-19 is  “similar to seasonal influenza”, It is not a killer virus.
  2. The PCR test used to estimate “confirmed positive cases” is flawed. Since March 2020, the Covid-19 “numbers” have been manipulated, hiked up.
  3. The overall validity of the PCR test (and estimates) as applied since January 2020 has been questioned (January 2021) by the WHO. (See our analysis in Chapter III)

“Fraudulent Marketing” of an “Unapproved Product”

Flashback to 2009. In a historic US Department of Justice decision in September 2009, Pfizer Inc. pleaded guilty to criminal charges. It was “The Largest Health Care Fraud Settlement” in the History of the US Department of Justice:

American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. … have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, … ” (September 2, 2009)

To view the C-Span Video Click Screen below 

 

Déjà Vu: Flash Forward to 2020-2021

How on Earth could you trust a Big Pharma vaccine conglomerate which pleaded guilty to criminal charges by the US Department of Justice including “fraudulent marketing” and “felony violation of the Food, Drug and Cosmetic Act”?

I should mention, however, that in 2009, Pfizer was so to speak “Put on Probation” by the US Department of Justice. It was obliged to enter into “a corporate integrity agreement” with the Inspector General of the Department of Health and Human Services (DHHS). “That agreement provided for “procedures and reviews to … avoid and promptly detect” misconduct on the part of Pfizer, Inc.

Johnson and Johnson and “The Opioid Epidemic” 

At the height of the corona crisis, barely covered by the media, coinciding with the launch of the Covid-19 vaccine in early November 2020, Johnson and Johnson (and its three distributors) (involved in the marketing of prescription opioids)  “reached a tentative $26 billion settlement with counties and cities that sued them for damages”. The class action law suit was “the largest federal court case in American history” (For further details see Chapter VI pertaining to “The Impacts on Mental Health”)

Are these legal antecedents relevant to an understanding of Big Pharma’s vaccine initiative?

Johnson and Johnson is  currently involved in the production and marketing of a Covid adenovirus viral vector vaccine which also entails genetic therapy. (The above J & J 26 billion dollar settlement is one among several law suits against J&J).

Human Guinea Pigs

In relation to the Covid Vaccine, “fraudulent marketing” is an understatement: The mRNA vaccine announced by Pfizer, Moderna Inc, Johnson and Johnson and AstraZeneka is an “unapproved drug” based on the “experimental” gene editing mRNA technology which has a bearing on the human genome.  

Moreover, the standard animal lab tests using mice or ferrets were not conducted.  Pfizer “went straight to human “guinea pigs.”

“Human tests began in late July and early August [2020]. Three months is unheard of for testing a new vaccine. Several years is the norm.” (F. William Engdahl, Global Research, November 2020)

This caricature by Large + JIPÉM  explains our predicament:

Mouse No 1: “Are You Going to get Vaccinated”,

Mouse No. 2: Are You Crazy, They Haven’t finished the Tests on Humans”

Un grand merci aux caricaturistes Large et JIPÉM

Dr. Michael Yeadon, a former Vice President of Pfizer has taken a firm stance

“All vaccines against the SARS-COV-2 virus are by definition novel. No candidate vaccine has been… in development for more than a few months.”:

“If any such vaccine is approved for use under any circumstances that are not EXPLICITLY experimental, I believe that recipients are being misled to a criminal extent.”

In early December,  Dr Michael Yeadon together with Dr. Wolfgang Wodarg “filed an application with the EMA, the European Medicine Agency responsible for EU-wide drug approval, for the immediate suspension of all SARS CoV 2 vaccine studies, in particular the BioNtech/Pfizer study on BNT162b (EudraCT number 2020-002641-42).

History of the SARS-CoV-2 Vaccine Project 

There are many contradictions. The analysis below addresses the earlier stages of the vaccine project as well as the role of the 201 Simulation under the auspices of the John Hopkins School of Medicine held in New York on  October 19, 2019.

The Covid vaccine is a multibillion dollar Big Pharma operation which will contribute to increasing the public debt of more than 150 national governments.

Supported by the fear campaign, Money rather than Public Health is the driving force behind this initiative.

The GSK-Pfizer Partnership 

Five months before the onset of the Covid-19 crisis, two of the largest Worldwide Pharma conglomerates decided to join hands in a strategic relationship. In August 2019, GSK confirmed the formation of a major partnership with Pfizer entitled the Consumer Health Joint Venture.

While the relationship is said to be limited to “trusted consumer health brands”, the agreement envisages joint financial procedures including joint multibillion dollar investment projects. While it does not constitute a merger, the GSK-Pfizer alliance implies selective integration and de facto collusion in many of the two companies’ activities including the vaccine market.

The completion of the joint venture with Pfizer marks the beginning of the next phase of our transformation of GSK. This is an important moment for the Group, laying the foundation for two great companies, one in Pharmaceuticals and Vaccines and one in Consumer Health.”  (GSK, August 1, 2019,  emphasis added)

This GSK-Pfizer relationship also encompasses a network of  partner pharmaceutical companies, research labs, virology institutes, military and biotech entities, etc. many of which are currently involved in the Covid vaccine initiative.

At present, a handful of multinational companies including GSK and Pfizer control 80% of the global vaccine market. Under the agreement between the two companies, GSK-Pfizer is slated to play a dominant and coordinated role in regards to the Covid-19 vaccine.

The October 2019 Coronavirus Event 201 Simulation Exercise

The coronavirus was initially named nCoV-19 by CEPI and the WHO: exactly the same name as that adopted in the WEF-Gates-John Hopkins Event 201 (2019-nCov) pertaining to a coronavirus simulation exercise held in Baltimore in mid October 2019.

The Event 201 John Hopkins simulation addressed the development of an effective vaccine in response to millions of cases (in the October 2019 simulation) of the 2019 nCoV. The simulation announced a scenario in which the entire population of the planet would be affected: “During the initial months of the pandemic, the cumulative number of cases [in the simulation] increases exponentially, doubling every week. And as the cases and deaths accumulate, the economic and societal consequences become increasingly severe.”

The scenario ends at the 18-month point, with 65 million deaths. The pandemic is beginning to slow due to the decreasing number of susceptible people. The pandemic will continue at some rate until there is an effective vaccine or until 80-90 % of the global population has been exposed. From that point on, it is likely to be an endemic childhood disease.

According to the WEF Video below, produced in relation to the 201 Simulation, “we ran a massive viral pandemic simulation.., 65 million deaths Worlwide.”.

See also the analysis of  F. William Engdahl on the 201 Simulation

Video Produced by the World Economic Forum in association with the 201 John Hopkins Simulation

Ironically, on January 30th 2020, the WHO defined the new virus as 2019-nCoV, i.e. the same name as that used in the 201 simulation in October 2019.

It was only later that Covid-19 was identified by the WHO not as a virus but as a disease: coronavirus disease (COVID-19), the Virus was identified as “severe acute respiratory syndrome” coronavirus 2 (SARS-CoV-2)

Two weeks after the virus had been formally identified by the People’s Republic of China (Jan 7, 2020), a vaccine for the novel coronavirus was announced by CEPI at the Davos World Economic Forum, January 20-24, 2020.

The Central Role of the Coalition for Epidemic Preparedness Innovations (CEPI)

The lead entity for the novel coronavirus vaccine initiative is the Coalition for Epidemic Preparedness Innovations (CEPI) an organization sponsored and financed by the World Economic Forum (WEF) and the Bill and Melinda Gates Foundation.

Note the chronology: The development of the 2019 nCoV vaccine was announced at the Davos World Economic Forum (WEF) a week prior to the official launching by the WHO of  a Worldwide Public Health Emergency (January 30) at a time when the number of “confirmed cases” Worldwide (outside China) was 83. (see Chapter II)

The pandemic was launched by the WHO on March 11. And five days later, barely covered by the media, the first tests involving human volunteers were conducted by Moderna in Seattle on March 16.

According to Richard Hatchett, CEO of  the Coalition for Epidemic Preparedness Innovations (CEPI) the project to develop a vaccine commenced not only prior to the discovery and identification of the coronavirus (January 7, 2020) but several months prior to the October 2019 simulation exercise.

“We did that in the last year or so [early 2019]. … ”

(scroll down for interview with Richard Hatchett)

CEPI is seeking a “monopoly” role in the vaccination business the objective of which is a “global vaccine project”, in partnership with a large number of “candidates”.

It announced funding for its existing partnership with Inovio and The University of Queensland (Australia). In addition, CEPI confirmed (January 23, 2020) its contract with Moderna, Inc. and the U.S. National Institute of Allergy and Infectious Diseases (NIAID) headed by Dr. Anthony Fauci, who has been instrumental in waging the fear and panic campaign across America: “Ten Times Worse than Seasonal Flu”. (See WEF Video below)

The presentation of the representative from Moderna Inc describing the features of the mRNA vaccine starts at 11’50”.

“We inject instructions … mRNA is a platform”

CEPI was dealing simultaneously with several pharmaceutical companies. The Moderna- NIAID agreement was implemented. The mRNA COVID-19 vaccine was launched in the US in late November 2020.

On January 31st, 2020 the day following the WHO’s official launching of the global public health emergency (PHEIC) and Trump’s decision to curtail air travel with China, CEPI announced its partnership with CureVac AG, a German-based  biopharmaceutical company.

A few days later, in early February 2020, CEPI “announced that major vaccine manufacturer GSK would allow its proprietary adjuvants— compounds that boost the effectiveness of vaccines — to be used in the response”. (The pandemic was officially launched on March 11).

There were many “potential vaccines in the pipeline” with “dozens of research groups around the world  racing to create a vaccine against COVID-19”.

The COV-19 Global Vaccination Program 

CEPI (on behalf of Gates-WEF, which funded the 201 simulation exercise) is currently playing a key role in a large scale Worldwide vaccination program in partnership with biotech companies, Big Pharma, government agencies as well as university laboratories.

The foregoing statement by CEPI was made nearly two months prior to the official declaration of a pandemic on March 11.

“We’re having conversations with a broad array of potential partners”.

And critical to those conversations is:

What’s the plan to make very large quantities of vaccine within a time frame that is potentially relevant to what people seem to be increasingly certain will be a pandemic, if it isn’t already there? …” [Richard Hatchett, CEPI CEO in interview with stat.news.com].  …

The underlying focus was to develop a global vaccine:

And part of that was doing a global survey of manufacturing capacity to think about where we wanted to plant the manufacturing of any successful products we were able to bring forward.

Of significance, Hatchett  confirmed that the project to develop a vaccine commenced not only prior to the discovery and identification of the coronavirus (January 7, 2020) but several months prior to the October 2019 201 simulation exercise.

“We did that in the last year or so. [early 2019]…  We are using the information that we have collected and have that team now thinking about opportunities for scaling vaccines of various different types. That is a work in progress. For some of the technologies the tech transfer [to a manufacturer] may be something that could be done in a time frame that was pertinent to the epidemic, potentially.

I think it is going to be really important to engage those folks who have access to really substantial production capacity. And having the big producers at the table — because of their depth, because of their experience, because of their internal resources — would be very, very important.

The candidate vaccines will be very, very quick. Dr. Anthony Fauci, director of NIAID [who has been spreading panic on network TV], is out in public as saying he thinks the clinical trial for the Moderna vaccine may be as early as the spring. (emphasis added)

What is now unfolding in real life is in some regards similar to the October 2019 201 Simulation exercise at John Hopkins.

The scenario is how to produce millions of vaccine shots on the presumption that the pandemic will spread Worldwide, and for that you need the Covid-19 “positive cases” to go fly high.

The CEPI sponsored vaccine conglomerates had already planned their investments well in advance of the global Worldwide health emergency (declared by the WHO on January 30, 2020):

I [Hachett] think part of the general strategy is to have a large number of candidates. [and] you want to have enough candidates that at least some of them are moving rapidly through the process.

And then for each candidate, you need to ask yourself the question: How do you produce that? … [And] how are you going to get to that point with production at a scale that is meaningful in the context of a disease that is going to infect the whole of society?(Interview conducted by Helen Branswell, statsnews, February 3, 2020)

Moderna Inc 

Moderna Inc based in Seattle was one of the several candidates involved and supported by CEPI.

Moderna announced on February 24th the development of “an experimental mRNA COVID-19 vaccine, known as mRNA-1273″. The initial batch of the vaccine has already been shipped to U.S. government researchers from the National Institute of Allergy and Infectious Diseases (NIAID)” headed by Dr. Antony Fauci.

While Moderna Inc initially stated that the first clinical trials would commence in late April, tests involving human volunteers started in mid-March in Seattle: (bear in mind the pandemic was officially launched on March 11)

.

Researchers in Seattle gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday — leading off a worldwide hunt for protection even as the pandemic surges.  …

Some of the study’s carefully chosen healthy volunteers, ages 18 to 55, will get higher dosages than others to test how strong the inoculations should be. Scientists will check for any side effects and draw blood samples to test if the vaccine is revving up the immune system, looking for encouraging clues like the NIH earlier found in vaccinated mice.

“We don’t know whether this vaccine will induce an immune response, or whether it will be safe. That’s why we’re doing a trial,” Jackson stressed. “It’s not at the stage where it would be possible or prudent to give it to the general population.” (FOX news local)

The Covid Vaccine and the ID2020 Digital Identity Platform

While CEPI had announced the launching of a global vaccine at the Davos World Economic Forum, another important and related endeavor was underway. It’s called the ID2020 Agenda, which, according to Peter Koenig constitutes “an electronic ID program that uses generalized vaccination as a platform for digital identity”.

“The program harnesses existing birth registration and vaccination operations to provide newborns with a portable and persistent biometrically-linked digital identity”. (Peter Koenig, March 2020)

The founding Partners of ID2020 are Microsoft, the Rockefeller Foundation and the Global Alliance for Vaccines and Immunization (GAVI) among others.

It is worth noting the timeline: The ID2020 Alliance held their Summit in New York, entitled “Rising to the Good ID Challenge”, on September 19, 2019, exactly one month prior to nCov-2019 simulation exercise entitled Event 201 at John Hopkins in New York:

Is it just a coincidence that ID2020 is being rolled out at the onset of what the WHO calls a Pandemic? – Or is a pandemic needed to ‘roll out’ the multiple devastating programs of ID2020? (Peter Koenig, March 2020)

ID2020 is part of a “World Governance” project which, if applied, would roll out the contours of what some analysts have described as a Global Police State encompassing through vaccination the personal details of several billion people Worldwide. According to Dr. David Martin (quoted by Makia Freeman):

“This is not a vaccine … using the term vaccine to sneak this thing under public health exemptions … This is a mRNA packaged in a fat envelope that is delivered to a cell. It is a medical device designed to stimulate the human cell into becoming a pathogen creator. It is not a vaccine! Vaccines actually are a legally defined term … under public health law … under CDC and FDA standards, and a vaccine specifically has to stimulate both an immunity within the person receiving it, but it also has to disrupt transmission.

In the Wake of the Lockdown. The Second Wave

The Second Wave: The fear campaign continues in the wake of the lockdown. A new lockdown is unfolding (December-January) in several countries.

Will the hardships of the economic and social crisis (coupled with a fear campaign) encourage people to get vaccinated?

To implement the Global Vaccine, the propaganda campaign must continue. The Truth must be suppressed. These are their “guidelines”, which must be confronted and challenged.

Several governments (aka corrupt politicians) including the US, UK, France, Germany, Canada as well as India have already provided the green light. Information and analysis on the features of the virus (similar to seasonal influential) is being suppressed by the media.

While Hydroxychloroquine (HCQ) has been used to treat patients in both Europe and North America, Big Pharma with the support of the governments is intent upon suppressing evidence on how COVID-19 can be cured, without the need of a vaccine. (See Chapter VI)

The Covid Vaccine and “Herd Immunity”: Changing the Definitions 

Herd immunity is an important concept in medicine. According to Healthline:

“It happens when so many people in a community become immune to an infectious disease that it stops the disease from spreading.

This can happen in two ways:

1. Many people contract the disease and in time build up an immune response to it (natural immunity).

2. Many people are vaccinated against the disease to achieve immunity.

Herd immunity can work against the spread of some diseases. There are several reasons why it often works.” (See Healthline)

The WHO has redefined herd immunity with a view to supporting the multibillion dollar Covid vaccine initiative:

Below (Left) is the official WHO definition (June 2020). And in November (Right) the WHO decided unilaterally to  redefine a fundamental medical concept, focussing solely on the role of vaccination in achieving herd immunity.

.

 

To our knowledge, the peer reviewed definition of herd immunity has not changed.

The new “definition” of the WHO visibly serves the interests of Big Pharma.

.

Flashback: The 2009 H1N1 Swine Flu Pandemic

Remember the 2009 H1N1 “pandemic” when Obama’s Council of Advisors on Science and Technology compared the H1N1 pandemic to the 1918 Spanish flu pandemic while reassuring the public that the latter was more deadly. (CBC: Get swine flu vaccine ready: U.S. advisers).

For further details see Michel Chossudovsky, August 2009 Study on H1N1 Pandemic)

Based on incomplete and scanty data, the WHO Director General Margaret Chan predicted with authority that: “as many as 2 billion people could become infected over the next two years — nearly one-third of the world population.” (World Health Organization as reported by the Western media, July 2009).

It was a multibillion bonanza for Big Pharma supported by the WHO’s Director-General Margaret Chan. 

In a subsequent statement Dr. Chan confirmed that:

“Vaccine makers could produce 4.9 billion pandemic flu shots per year in the best-case scenario”,Margaret Chan, Director-General, World Health Organization (WHO), quoted by Reuters, 21 July 2009).

Swine flu could strike up to 40 percent of Americans over the next two years and as many as several hundred thousand could die if a vaccine campaign and other measures aren’t successful.” (Official Statement of Obama Administration, Associated Press, 24 July 2009).

There was no H1N1 pandemic affecting 2 billion people. Millions of doses of swine flu vaccine had been ordered by national governments from Big Pharma.

Millions of vaccine doses were subsequently destroyed: a financial bonanza for Big Pharma, an expenditure crisis for national governments.

There was no investigation into who was behind this multibillion dollar fraud. Several critics said that the H1N1 Pandemic was “Fake”

The Parliamentary Assembly of the Council of Europe (PACE), a human rights watchdog, is publicly investigating the WHO’s motives in declaring a pandemic. Indeed, the chairman of its influential health committee, epidemiologist Wolfgang Wodarg, has declared that the “false pandemic” is “one of the greatest medicine scandals of the century.” (Michael Fomento, Forbes, February 10, 2010)

Michael Fomento  concludes:

Even within the agency, the director of the WHO Collaborating Center for Epidemiology in Munster, Germany, Dr. Ulrich Kiel, has essentially labeled the pandemic a hoax. “We are witnessing a gigantic misallocation of resources [$18 billion so far] in terms of public health,” he said.

They’re right. This wasn’t merely overcautiousness or simple misjudgment. The pandemic declaration and all the Klaxon-ringing since reflect sheer dishonesty motivated not by medical concerns but political ones.

Unquestionably, swine flu has proved to be vastly milder than ordinary seasonal flu. It kills at a third to a tenth the rate, according to U.S. Centers for Disease Control and Prevention estimates. Data from other countries like France and Japan indicate it’s far tamer than that.

H1N1 2009 Vaccine Causes Brain Damage to Children : GSK’s ArepanrixTD applied in Canada

In Memory of a Little Girl Called Amina Abudu

See complete article here

The WHO’s H1N1 pandemic was declared in June 11, 2009. GSK was on contract to the Canadian government. The GSK’s ArepandrixTM vaccine was delivered to Canadian health authorities within less than four months.

“As a result, an impressive 45% of Canadians received protection from the H1N1 virus by being vaccinated with GSK’s ArepanrixTM” according to GSK’S President-CEO Paul Lucas in a statement on  October 9 2009 to Canada’s Senate Standing Committee on Social Affairs, Science and Technology.

Within four months?. Does that give them Time to Test????

Lots of people in Canada fell sick after receiving the H1N1 ArepanrixTD vaccine.

And that vaccine killed a little girl called Amina Abudu, which then led to a ten year lawsuit against GSK.

A vaccine was rushed to market, and the five year old was among millions of Canadians to get the shot, amid widespread fears about the new pathogen.

Five days later, Amina’s older brother found her lying unconscious in the bathroom of the family’s east-end Toronto home. She was dead.

Her devastated parents came to blame the flu shot itself and sued the vaccine’s manufacturer, Glaxo Smith Kline (GSK), for $4.2 million. The little-noticed trial of that lawsuit drew toward a close on Tuesday, a rare judicial airing in Canada of a vaccine’s alleged side effects.

The parents’ lawyer, Jasmine Ghosn, alleged the preventive drug was brought out quickly and without proper testing during a chaotic flu season, as the federal government exerted “intense pressure” on Canadians to get immunized. (National Post, November 2019)

Screenshot of National Post. Death of Canadian girl in 2009  (Report is dated November 2019

It took ten years for a judgment. The Family lost. GSK declined responsibility for her death. And the Canadian government reimbursed GSK’s legal expenses.

That lawsuit against GSK should be reopened. Canada’s government bears the burden of responsibility.

ArepanrixTD (2009) vs PandemrixTM (2009)

GSK has casually acknowledged that the ArepanrixTD which was used in Canada is “similar” to the GSK’s PandemrixTM applied in the UK and the EU, which led to brain damage in Children. It was subsequently withdrawn. But ArepandrixTD applied in Canada prevailed.  An ArepandrixTD (2010) was subsequently released the following year (and compared to PandemrixTD (2009)

GSK acknowledges that PandemrixTD (2009) causes narcolepsy, which is categorized as “a chronic neurological disorder that affects the brain’s ability to control sleep-wake cycles.”

COVID-19 Vaccine is Déjà Vu. Lets not be taken in again.

Important Lessons to be Learned from the 2009 H1N1 Pandemic

The COVID-19 “pandemic” is far more serious and diabolical than the 2009 H1N1. The COV-19 pandemic has provided a pretext and a justification for destabilizing the economies of entire countries, impoverishing large sectors of the World population. Unprecedented in modern history.

And it is important that we act cohesively and in solidarity with those who are victims of this crisis.

People’s lives are in a freefall and their purchasing power has been destroyed.

What kind of twisted social structure awaits us in the wake of the lockdown?

Can we trust the World Health Organization (WHO) and the powerful economic interest groups behind it. The answer is obvious.

Can we trust the main actors behind the multibillion dollar global vaccination project?

Can we trust the Western media which has led the fear campaign?

Disinformation sustains the lies and fabrications.

Can we trust our “corrupt” governments? Our national economy has been devastated.

In recent developments, the Covid vaccine is being implemented in a large number of countries.

Dr. Wolfgang Wodarg who revealed the fraud behind H1N1 is actively involved together with Dr. Michael Yeadon in the campaign against the Covid-19 vaccine.

.


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


About the author:

Michel Chossudovsky is an award-winning author, Professor of Economics (emeritus) at the University of Ottawa, Founder and Director of the Centre for Research on Globalization (CRG), Montreal, Editor of Global Research.  He has taught as visiting professor in Western Europe, Southeast Asia, the Pacific and Latin America. He has served as economic adviser to governments of developing countries and has acted as a consultant for several international organizations. He is the author of eleven books including The Globalization of Poverty and The New World Order (2003), America’s “War on Terrorism” (2005), The Global Economic Crisis, The Great Depression of the Twenty-first Century (2009) (Editor), Towards a World War III Scenario: The Dangers of Nuclear War (2011), The Globalization of War, America's Long War against Humanity (2015). He is a contributor to the Encyclopaedia Britannica.  His writings have been published in more than twenty languages. In 2014, he was awarded the Gold Medal for Merit of the Republic of Serbia for his writings on NATO's war of aggression against Yugoslavia. He can be reached at [email protected]

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]